Lupus & Connective Tissue Diseases
Opinion
Testing for latent tuberculosis infection
The newest recommendations focus on when and for whom it is best to use the tuberculin skin test, Interferon Gamma Release Assay, or both.
News
FDA approves first therapy treatment for EGPA
Approval of using mepolizumab for EGPA was based on data from a 52-week clinical trial that compared it with placebo, according to the FDA.
News from the FDA/CDC
Health disparities in rural America: Chronic conditions
Black and American Indian/Alaska Native adults most likely to have multiple chronic health conditions.
Conference Coverage
Nonadherence to lupus drugs may play a role in frequent hospitalization
SAN DIEGO – A higher risk for hospitalization also occurred among young, male, and African-American patients.
Conference Coverage
Rheumatology 911: Inside the rheumatologic emergency
SAN DIEGO – Clinical intuition is key to handling medical crises in rheumatology, Dr. Bharat Kumar says.
Conference Coverage
Blisibimod shows mixed results for lupus in phase 3 trial
SAN DIEGO – The drug did not meet its primary endpoint but was associated with steroid sparing, decreased urine protein, and improved biomarker...
Conference Coverage
Kidney transplant for GPA boosts survival
SAN DIEGO – Granulomatosis with polyangiitis patients sometimes develop renal failure.
Conference Coverage
Anabasum shows promise in treating skin-predominant dermatomyositis, systemic sclerosis
SAN DIEGO – The investigational drug met primary endpoints and showed good safety in two phase 2 studies.
Conference Coverage
Novel agent found to benefit Sjögren’s patients
SAN DIEGO – Multiple doses of the investigational agent CFZ533 administered for 24 weeks in patients with primary Sjögren’s syndrome were safe and...
Conference Coverage
Race may transcend social, geographical parameters in lupus mortality
SAN DIEGO – SLE mortality parameters did not vary among socially advantaged and disadvantaged black Americans.
Conference Coverage
Proposed SLE classification criteria prove highly sensitive, specific
SAN DIEGO – New classification criteria for systemic lupus erythematosus had a sensitivity of 98% and a specificity of 97%.